IEQ Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $989K | Buy |
38,255
+1,107
| +3% | +$28.6K | 0.01% | 866 |
|
2025
Q1 | $379K | Buy |
37,148
+35,683
| +2,436% | +$364K | ﹤0.01% | 1096 |
|
2024
Q4 | $20.4K | Hold |
1,465
| – | – | ﹤0.01% | 1320 |
|
2024
Q3 | $28.6K | Hold |
1,465
| – | – | ﹤0.01% | 1143 |
|
2024
Q2 | $27.3K | Sell |
1,465
-145
| -9% | -$2.7K | ﹤0.01% | 986 |
|
2024
Q1 | $22.6K | Buy |
1,610
+704
| +78% | +$9.86K | ﹤0.01% | 963 |
|
2023
Q4 | $7.68K | Buy |
906
+133
| +17% | +$1.13K | ﹤0.01% | 924 |
|
2023
Q3 | $6.91K | Hold |
773
| – | – | ﹤0.01% | 937 |
|
2023
Q2 | $6.67K | Hold |
773
| – | – | ﹤0.01% | 896 |
|
2023
Q1 | $8.15K | Hold |
773
| – | – | ﹤0.01% | 888 |
|
2022
Q4 | $26.2K | Sell |
773
-3,786
| -83% | -$128K | ﹤0.01% | 805 |
|
2022
Q3 | $219K | Sell |
4,559
-300
| -6% | -$14.4K | 0.01% | 747 |
|
2022
Q2 | $277K | Sell |
4,859
-26
| -0.5% | -$1.48K | 0.01% | 624 |
|
2022
Q1 | $395K | Buy |
4,885
+15
| +0.3% | +$1.21K | 0.01% | 563 |
|
2021
Q4 | $987K | Buy |
4,870
+3,779
| +346% | +$766K | 0.02% | 310 |
|
2021
Q3 | $294K | Buy |
+1,091
| New | +$294K | 0.01% | 562 |
|
2021
Q1 | – | Sell |
-17,771
| Closed | -$4.53M | – | 491 |
|
2020
Q4 | $4.53M | Buy |
+17,771
| New | +$4.53M | 0.2% | 83 |
|